Vol 82, No 4 (2024)
Clinical vignette
Published online: 2024-03-06

open access

Page views 341
Article views/downloads 337
Get Citation

Connect on Social Media

Connect on Social Media

Patent ductus arteriosus: An unexpected diagnosis in adulthood

Fabiana Duarte1, Maria Inês Barradas1, Inês Coutinho dos Santos1, Raquel Dourado1, Dinis Martins1
Pubmed: 38493465
Pol Heart J 2024;82(4):460-461.

Abstract

Not available

CLINICAL VIGNETTE

Patent ductus arteriosus: An unexpected diagnosis in adulthood

Fabiana DuarteMaria Inês BarradasInês Coutinho dos SantosRaquel DouradoDinis Martins
Department of Cardiology, Hospital of Divino Espírito Santo, Ponta Delgada, Portugal

Correspondence to:

Fabiana Duarte, MD,

Department of Cardiology

Hospital of Divino Espírito Santo of Ponta Delgada,

Av. D. Manuel I, 9500-370, Ponta Delgada, Portugal,

phone: +351 296 203 000,

e-mail: fabiana.s.duarte@azores.gov.pt

Copyright by the Author(s), 2024

DOI: 10.33963/v.phj.99551

Received: October 6, 2023

Accepted: February 25, 2024

Early publication date: March 6, 2024

A 51-year-old male patient was referred to the cardiology clinic due to a continuous murmur (grade 4/6) heard throughout all heart areas. The patient experienced occasional palpitations and dyspnoea during moderate exertion. His medical history included hypertension, atrial fibrillation, and smoking.

The diagnostic workup included an electrocardiogram with nonspecific intraventricular conduction delay. A transthoracic echocardiogram (TTE) was performed, revealing moderate left chamber enlargement, and moderate mitral valve regurgitation. No indirect signs of pulmonary hypertension were evident, but persistent patent ductus arteriosus (PDA) was suspected (Figure 1AB; Supplementary material, Videos S1S4).

Figure 1. AB. Transthoracic echocardiogram showed moderate mitral valve regurgitation, which raised the suspicion of a persistent patent ductus arteriosus. C. CMR revealing severe left chamber enlargement. D. CMR confirmed a PDA (10 × 12 mm) between the left pulmonary artery and the descending aorta, with a Qp:Qs ratio of 2:1. E. Angiographic evaluation confirmed the presence and size of the ductus. F. Percutaneous transcatheter closure of PDA with an Amplatzer device, with no residual shunt
Abbreviations: Ao, aorta; CMR, cardiac magnetic resonance; PA, pulmonary artery

Cardiac magnetic resonance (CMR) confirmed severe left chamber enlargement, preserved biventricular function, and showed a 10 × 12 mm PDA between the left pulmonary artery and the descending aorta (Qp:Qs ratio 2:1) (Figure 1CD; Supplementary material, Videos S5S8). Right heart catheterization revealed an elevated mean pulmonary arterial pressure (mPAP 32 mm Hg) and normal pulmonary vascular resistance (PVR 0.49 WU), consistent with isolated post-capillary pulmonary hypertension.

This was a moderate PDA with left-to-right shunting associated with a high-frequency continuous murmur as a definitive indication on physical evaluation, with a crescendo systolic component and a decrescendo diastolic one. According to the Krichenko angiographic classification, it was a conical ductus with constriction near the pulmonary artery (Type A). Due to left ventricular volume overload in the absence of elevated pulmonary vascular resistances, the patient was considered for PDA closure. A percutaneous transcatheter occlusion using an Amplatzer device was performed. The procedure was successful without immediate complications (Figure 1EF; Supplementary material, Videos S9S11).

TTE reevaluation at 6 months post-procedure showed a well-positioned device, with no residual shunting. The patient reported clinical improvement, experiencing dyspnea only during high-intensity exertion, and resumed regular daily and professional activities.

PDA, a congenital heart defect, is considered abnormal when it persists into adulthood, and its clinical impact depends on its size, pulmonary-to-systemic-flow ratio, and underlying cardiac conditions [1]. In late adulthood, PDA is a rare diagnosis and represents an incidental finding suggested by physical examination and confirmed by TTE [2]. Additional imaging methods, such as CMR, are useful to confirm the diagnosis and to determine the magnitude of the shunt. Right cardiac catheterization is not mandatory for diagnostic purposes, but it is essential to assess the presence and degree of pulmonary hypertension and to calculate pulmonary vascular resistance, which can constitute a contraindication to closing the shunt [1, 2]. Our patient was not cyanotic, and he showed no clubbing of his toes; otherwise, a suspicion of Eisenmenger’s syndrome should be raised.

In adult patients who meet the criteria for PDA closure, percutaneous occlusion is preferred over the surgical approach, usually with ductal occluders, such as Amplatzer devices [3, 4]. PDA closure is contraindicated in patients with severe and irreversible pulmonary hypertension, as in the case of patients with Eisenmenger syndrome, where PDA closure may worsen clinical symptoms and reduce cardiac output [1, 4].

Supplementary material

Supplementary material is available at https://journals.viamedica.pl/polish_heart_journal.

Article information

Conflict of interest: None declared.

Funding: None.

Open access: This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, which allows downloading and sharing articles with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. For commercial use, please contact the journal office at polishheartjournal@ptkardio.pl

REFERENCES

  1. Baumgartner H, De Backer J, Baumgartner H, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021; 42(6): 563645, doi: 10.1093/eurheartj/ehaa554, indexed in Pubmed: 32860028.
  2. Pushparajah K. Non-invasive imaging in the evaluation of cardiac shunts for interventional closure. Front Cardiovasc Med. 2021; 8: 651726, doi: 10.3389/fcvm.2021.651726, indexed in Pubmed: 34222361.
  3. Wilson WM, Shah A, Osten MD, et al. Clinical outcomes after percutaneous patent ductus arteriosus closure in adults. Can J Cardiol. 2020; 36(6): 837843, doi: 10.1016/j.cjca.2019.11.025, indexed in Pubmed: 32536374.
  4. Backes CH, Hill KD, Shelton EL, et al. Patent ductus arteriosus: a contemporary perspective for the pediatric and adult cardiac care provider. J Am Heart Assoc. 2022; 11(17): e025784, doi: 10.1161/JAHA.122.025784, indexed in Pubmed: 36056734.